XML 46 R86.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Schedule I Condensed Balance Sheets (Details) - USD ($)
$ in Millions
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Current assets:        
Cash and cash equivalents $ 10,985 $ 10,866 $ 11,981 $ 10,430
Total current assets 42,634 38,692    
Other assets 9,334 4,326    
Total assets 173,889 152,221 139,058  
Current liabilities:        
Accounts payable and accrued liabilities 19,005 16,705    
Commercial paper and current maturities of long-term debt 3,870 1,973    
Total current liabilities 61,782 53,209    
Long-term debt, less current maturities 36,808 34,581    
Other liabilities 10,144 5,730    
Total liabilities 111,727 95,994    
Commitments and contingencies (Note 4)      
Shareholders’ equity:        
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding 0 0    
Common stock, $0.01 par value - 3,000 shares authorized; 948 and 960 issued and outstanding 9 10    
Additional paid-in capital 7 0    
Retained earnings 61,178 55,846    
Accumulated other comprehensive loss (3,578) (4,160)    
Total liabilities and shareholders’ equity 173,889 152,221    
Parent Company [Member]        
Current assets:        
Cash and cash equivalents 46 434 $ 359 $ 180
Other current assets 787 197    
Total current assets 833 631    
Equity in net assets of subsidiaries 93,467 83,244    
Long-term notes receivable from subsidiaries 5,079 4,461    
Other assets 794 972    
Total assets 100,173 89,308    
Current liabilities:        
Accounts payable and accrued liabilities 688 618    
Current portion of notes payable to subsidiaries 750 714    
Commercial paper and current maturities of long-term debt 3,548 1,744    
Total current liabilities 4,986 3,076    
Long-term debt, less current maturities 35,926 33,490    
Long-term notes payable to subsidiaries 1,314 560    
Other liabilities 331 486    
Total liabilities 42,557 37,612    
Shareholders’ equity:        
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding 0 0    
Common stock, $0.01 par value - 3,000 shares authorized; 948 and 960 issued and outstanding 9 10    
Additional paid-in capital 7 0    
Retained earnings 61,178 55,846    
Accumulated other comprehensive loss (3,578) (4,160)    
Total UnitedHealth Group shareholders’ equity 57,616 51,696    
Total liabilities and shareholders’ equity $ 100,173 $ 89,308